MANAGEMENT OF PERITONEAL METASTASES IN EPITHELIAL OVARIAN, FALLOPIAN TUBE AND PRIMARY PERITONEAL CARCINOMA

被引：0
|
作者：
Gao, Yunong [1 ]
机构：
[1] Peking Univ Canc Hosp, Dept Gynecol Oncol, Beijing, Peoples R China
来源：
ANTICANCER RESEARCH | 2015年 / 35卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
FBO3B06
引用
收藏
页码：4301 / 4302
页数：2
相关论文
共 50 条
  • [41] Gemcitabine plus cisplatin in recurrent ovarian, fallopian tube, and primary peritoneal cancer
    Eyada, Mostafa
    Fellman, Bryan M.
    Patel, Shrina
    Michael, Victoria
    Soliman, Pamela T.
    Sims, Travis T.
    How, Jeffrey Andrew
    Jazaeri, Amir A.
    Fleming, Nicole D.
    Ramondetta, Lois M.
    Westin, Shannon Neville
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [42] Chemotherapy completion in the older adults with epithelial ovarian, fallopian tube, and primary peritoneal cancer at a university hospital in Thailand
    Assavapokee, Nicha
    Phoolcharoen, Natacha
    Santibenchakul, Somsook
    Lertkhachonsuk, Ruangsak
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (SUPPL_4) : A69 - A70
  • [43] Bevacizumab Combination Therapy: A Review of its Use in Patients with Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
    Sohita Dhillon
    BioDrugs, 2013, 27 : 375 - 392
  • [44] Intravenous/Intraperitoneal Paclitaxel and Intraperitoneal Carboplatin in Patients With Epithelial Ovarian, Fallopian Tube, or Peritoneal Carcinoma A Feasibility Study
    Nagao, Shoji
    Iwasa, Norihiro
    Kurosaki, Akira
    Nishikawa, Tadaaki
    Ohishi, Rie
    Hasegawa, Kosei
    Goto, Tomoko
    Fujiwara, Keiichi
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2012, 22 (01) : 70 - 75
  • [45] Management of primary peritoneal and fallopian tube carcinomas in the platinate/taxane era
    Mendivil, A.
    Hunter, M. I.
    Han, E.
    Tewari, K. S.
    GYNECOLOGIC ONCOLOGY, 2008, 108 (03) : S123 - S123
  • [46] EFFECTIVENESS OF ORAL ETOPOSIDE IN RECURRENT OR REFRACTORY EPITHELIAL OVARIAN CANCER, PRIMARY PERITONEAL CANCER AND FALLOPIAN TUBE CANCER
    Kongsawatvorakul, C.
    Charakorn, C.
    Chittithaworn, S.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 742 - 742
  • [47] Bevacizumab Combination Therapy: A Review of its Use in Patients with Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
    Dhillon, Sohita
    BIODRUGS, 2013, 27 (04) : 375 - 392
  • [48] Phase II study of bevacizumab and pemetrexed for recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal cancer
    Hagemann, Andrea R.
    Novetsky, Akiva P.
    Zighelboim, Israel
    Gao, Feng
    Massad, L. Stewart
    Thaker, Premal H.
    Powell, Matthew A.
    Mutch, David G.
    Wright, Jason D.
    GYNECOLOGIC ONCOLOGY, 2013, 131 (03) : 535 - 540
  • [49] Phase II trial of bevacizumab and pemetrexed for recurrent or persistent epithelial ovarian, fallopian tube, or primary peritoneal cancer
    Hagemann, Andrea R.
    Zighelboim, Israel
    Novetsky, Akiva Pesach
    Gao, Feng
    Massad, L. Stewart
    Thaker, Premal H.
    Powell, Matthew A.
    Mutch, David Gardner
    Wright, Jason D.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [50] Effectiveness of oral etoposide in recurrent or refractory epithelial ovarian cancer, primary peritoneal cancer and fallopian tube cancer
    Kongsawatvorakul, Chompunoot
    Charakorn, Chuenkamon
    Chittithaworn, Suwicha
    Lertkhachonsuk, Arb-Aroon
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2022, 42 (06) : 2331 - 2335
12345